These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4683425)

  • 1. Hemolysis by diphenylsulfones: comparative effects of DDS and hydroxylamine-DDS.
    Glader BE; Conrad ME
    J Lab Clin Med; 1973 Feb; 81(2):267-72. PubMed ID: 4683425
    [No Abstract]   [Full Text] [Related]  

  • 2. The in vitro action of dapsone and its derivatives on normal and G6PD-deficient red cells.
    Scott GL; Rasbridge MR
    Br J Haematol; 1973 Mar; 24(3):307-17. PubMed ID: 4713632
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of ethanol on the detoxification of hydrogen peroxide induced by ascorbic acid in normal erythrocytes and those with glucose-6-phosphate dehydrogenase deficiency].
    Coutinho V
    Sangre (Barc); 1984; 29(1):10-4. PubMed ID: 6719314
    [No Abstract]   [Full Text] [Related]  

  • 4. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
    Grossman S; Budinsky R; Jollow D
    J Pharmacol Exp Ther; 1995 May; 273(2):870-7. PubMed ID: 7752092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two mechanisms for toxic effects of hydroxylamines in human erythrocytes: involvement of free radicals and risk of potentiation.
    Evelo CT; Spooren AA; Bisschops RA; Baars LG; Neis JM
    Blood Cells Mol Dis; 1998 Sep; 24(3):280-95. PubMed ID: 10087986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions.
    Reilly TP; Woster PM; Svensson CK
    J Pharmacol Exp Ther; 1999 Mar; 288(3):951-9. PubMed ID: 10027831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced hemolysis: biochemical considerations.
    Shahidi NT
    Birth Defects Orig Artic Ser; 1970 Jun; 6(2):9-15. PubMed ID: 5522339
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemolysis and Metabolic Lesion of G6PD Deficient RBCs in Response to Dapsone Hydroxylamine in a Humanized Mouse Model.
    Dziewulska KH; Reisz JA; Hay AM; D'Alessandro A; Zimring JC
    J Pharmacol Exp Ther; 2023 Sep; 386(3):323-330. PubMed ID: 37348965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the interaction between hydroxylamine analogues and oxyhemoglobin in intact erythrocytes.
    Spooren AA; Evelo CT
    Blood Cells Mol Dis; 2000 Aug; 26(4):373-86. PubMed ID: 11042038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attempts to predict the hemolytic potential of drugs in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type by an in vitro test.
    Bashan N; Peleg N; Moses SW
    Isr J Med Sci; 1988 Jan; 24(1):61-4. PubMed ID: 3346155
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemolytic drugs aniline and dapsone induce iron release in erythrocytes and increase the free iron pool in spleen and liver.
    Ciccoli L; Ferrali M; Rossi V; Signorini C; Alessandrini C; Comporti M
    Toxicol Lett; 1999 Oct; 110(1-2):57-66. PubMed ID: 10593595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic interactions in G6PD deficiency and development of an in vitro test to predict a drug's hemolytic potential.
    Magon A; Leipzig RM; Bloom K; Brewer GJ
    Prog Clin Biol Res; 1981; 55():709-24. PubMed ID: 7291202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dapsone induces oxidative stress and impairs antioxidant defenses in rat liver.
    Veggi LM; Pretto L; Ochoa EJ; Catania VA; Luquita MG; Taborda DR; Sánchez Pozzi EJ; Ikushiro S; Coleman MD; Roma MG; Mottino AD
    Life Sci; 2008 Aug; 83(5-6):155-63. PubMed ID: 18602405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of copper on the erythrocyte hexose monophosphate shunt pathway.
    Metz EN; Sagone AL
    J Lab Clin Med; 1972 Sep; 80(3):405-13. PubMed ID: 5055388
    [No Abstract]   [Full Text] [Related]  

  • 15. In Vitro Protective Effect and Antioxidant Mechanism of Resveratrol Induced by Dapsone Hydroxylamine in Human Cells.
    Albuquerque RV; Malcher NS; Amado LL; Coleman MD; Dos Santos DC; Borges RS; Valente SA; Valente VC; Monteiro MC
    PLoS One; 2015; 10(8):e0134768. PubMed ID: 26284371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrocyte glutathione peroxidase deficiency. Biochemical studies on the mechanisms of drug-induced hemolysis.
    Steinberg MH; Necheles TF
    Am J Med; 1971 Apr; 50(4):542-6. PubMed ID: 5572598
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia.
    Grossman SJ; Jollow DJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):118-25. PubMed ID: 3335994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A methemoglobin-dependent and plasma-stimulated experimental model of oxidative hemolysis.
    Benatti U; Morelli A; Damiani G; De Flora A
    Biochem Biophys Res Commun; 1982 Jun; 106(4):1183-90. PubMed ID: 6810891
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of some metabolites of hemolytic drugs on young and old, normal and G-6-PD-deficient human erythrocytes.
    Fraser IM; Tilton BE; Vesell ES
    Ann N Y Acad Sci; 1971 Jul; 179():644-53. PubMed ID: 5285395
    [No Abstract]   [Full Text] [Related]  

  • 20. Procabazine induced oxidative haemolysis: relationship in vivo red cell survival.
    Sponzo RW; Arseneau JC; Canellos GP
    Br J Haematol; 1974 Aug; 27(4):587-95. PubMed ID: 4417500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.